Yongqian Li

Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

S. Tu, Lung-Ji Chang, Jilong Yang, 2020, Frontiers in Immunology.